Evaluating the Effects of Subnormothermic Perfusion with AP39 in a Novel Blood-Free Model of Ex Vivo Kidney Preservation and Reperfusion
Authors:
- Smriti JuriasinganiSJSmriti Juriasingani
- Ashley JacksonAJAshley Jackson
- Max Yulin ZhangMZMax Yulin Zhang
- Aushanth RuthirakanthanARAushanth Ruthirakanthan
- George J. DugbarteyGDGeorge J. Dugbartey
- Emrullah SogutdelenESEmrullah Sogutdelen
- Max LevineMLMax Levine
- Moaath MandurahMMMoaath Mandurah
- Matthew WhitemanMWMatthew Whiteman
- Patrick LukePLPatrick Luke
- Alp SenerASAlp Sener
Open Access
- 2 July 2021
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 22 (13) , 7180
Abstract
The use of blood for normothermic and subnormothermic kidney preservation hinders the translation of these approaches and promising therapeutics. This study evaluates whether adding hydrogen sulfide donor AP39 to Hemopure, a blood substitute, during subnormothermic perfusion improves kidney outcomes. After 30 min of renal pedicle clamping, porcine kidneys were treated to 4 h of static cold storage (SCS-4 °C) or subnormothermic perfusion at 21 °C with Hemopure (H-21 °C), Hemopure + 200 nM AP39 (H200nM-21 °C) or Hemopure + 1 µM AP39 (H1µM-21 °C). Then, kidneys were reperfused with Hemopure at 37 °C for 4 h with metabolic support. Perfusate composition, tissue oxygenation, urinalysis and histopathology were analyzed. During preservation, the H200nM-21 °C group exhibited significantly higher urine output than the other groups and significantly higher tissue oxygenation than the H1µM-21 °C group at 1 h and 2h. During reperfusion, the H200nM-21 °C group exhibited significantly higher urine output and lower urine protein than the other groups. Additionally, the H200nM-21 °C group exhibited higher perfusate pO2 levels than the other groups and significantly lower apoptotic injury than the H-21 °C and the H1µM-21 °C groups. Thus, subnormothermic perfusion at 21 °C with Hemopure + 200 nM AP39 improves renal outcomes. Additionally, our novel blood-free model of ex vivo kidney preservation and reperfusion could be useful for studying other therapeutics.Keywords
Funding Information
- Physicians' Services Incorporated Foundation (18-17)
- Kidney Foundation of Canada (180015)
This publication has 28 references indexed in Scilit:
- Hydrogen Sulfide Treatment Mitigates Renal Allograft Ischemia-Reperfusion Injury during Cold Storage and Improves Early Transplant Kidney Function and Survival Following Allogeneic Renal TransplantationJournal of Urology, 2015
- Subnormothermic machine perfusion for preservation of porcine kidneys in a donation after circulatory death modelTransplant International, 2014
- Normothermic machine perfusion of the kidney: better conditioning and repair?Transplant International, 2014
- The synthesis and functional evaluation of a mitochondria-targeted hydrogen sulfide donor, (10-oxo-10-(4-(3-thioxo-3H-1,2-dithiol-5-yl)phenoxy)decyl)triphenylphosphonium bromide (AP39)MedChemComm, 2014
- Bovine HemoglobinJournal of Pharmacy Practice, 2012
- Deterioration of Endothelial and Smooth Muscle Cell Function in DCD Kidneys After Static Cold Storage in IGL-1 or UWJournal of Surgical Research, 2009
- Cold ischemic injury of transplanted kidneys: new insights from experimental studiesAmerican Journal of Physiology-Renal Physiology, 2004
- Cold ischemia and the reduced long-term survival of cadaveric renal allograftsKidney International, 2004
- Comparison of Mortality in All Patients on Dialysis, Patients on Dialysis Awaiting Transplantation, and Recipients of a First Cadaveric TransplantNew England Journal of Medicine, 1999
- A study of the quality of life and cost-utility of renal transplantationKidney International, 1996